DTIL Precision BioSciences, Inc.

Develops technology to produce custom, genome-editing enzymes for human health and biological research

$8.21  -0.51 (-5.85%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/27/2019
Outstanding shares:  60,767,307
Average volume:  462,214
Market cap:   $529,890,917
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74019P108
ISIN:        US74019P1084
Sedol:      BJ0M2S0
Valuation   (See tab for details)
PE ratio:   -15.67
PB ratio:   4.85
PS ratio:   4.49
Return on equity:   -31.31%
Net income %:   -26.91%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy